4D Pharma Plc ADR (LBPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2021 | 02-2021 | 12-2020 | 11-2020 | 08-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -77,508 | -30,495 | -30,495 | -520 | -324 |
| Depreciation Amortization | 727 | 1,572 | 1,572 | N/A | N/A |
| Accounts receivable | 340 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 302 | 2,677 | 2,677 | N/A | N/A |
| Other Working Capital | -1,109 | 1,309 | 1,309 | 242 | 161 |
| Other Operating Activity | 61,200 | -2,333 | -2,333 | -47 | -46 |
| Operating Cash Flow | $-16,048 | $-27,270 | $-27,270 | $-325 | $-210 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -164 | -211 | -211 | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | -204 | -102 |
| Purchase Sale Intangibles | N/A | -19 | -19 | N/A | N/A |
| Other Investing Activity | 0 | -19 | -19 | 28,056 | 28,056 |
| Investing Cash Flow | $-164 | $-230 | $-230 | $27,852 | $27,954 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 2,102 | 292 |
| Debt Repayment | N/A | N/A | N/A | -1,580 | N/A |
| Common Stock Issued | 39,004 | 36,382 | 36,382 | N/A | N/A |
| Common Stock Repurchased | N/A | N/A | N/A | -28,056 | -28,056 |
| Other Financing Activity | -6,059 | -1,915 | -1,915 | 0 | 0 |
| Financing Cash Flow | $32,945 | $34,467 | $34,467 | $-27,534 | $-27,764 |
| Exchange Rate Effect | N/A | -8 | -8 | N/A | N/A |
| Beginning Cash Position | 12,266 | 5,031 | 5,031 | 26 | 26 |
| End Cash Position | 28,999 | 11,990 | 11,990 | 19 | 7 |
| Net Cash Flow | $16,733 | $6,959 | $6,959 | $-7 | $-20 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,048 | -27,270 | -27,270 | -325 | -210 |
| Capital Expenditure | -164 | -211 | -211 | N/A | N/A |
| Free Cash Flow | -16,212 | -27,481 | -27,481 | -325 | -210 |